TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MXCT

MaxCyte Inc

Healthcare · Medical Devices

1.20$ +0.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow MXCT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– +1.4% +13.3% +35.2% +140.7% +78.3% +70.8% +35.9% +89.5% +69.2% -5.5% +19.2%
– -98.7% +12,741.7% +233.9% +157.4% +32.3% +41.1% +222.0% +47.7% +18.9% -6.4% -29.6%
– – – – +142.8% +24.8% +52.4% +203.1% +37.9% – – –
– – -38.1% -177.5% – – -153.2% – – – -119.7% –
– -35.7% +131.5% +178.7% +16.4% +79.1% +63.0% +85.0% +381.9% -80.0% -55.4% +7.1%
– -35.7% +131.5% +178.7% +528.7% – -3,747.5% +1,076.3% -87.3% – -87.4% +274.1%
– – – – – – – – -98.8% -90.7% +70.6% –
– – – – -77.6% +4,656.3% -58.1% +7,731.2% -100.0% – – –
– -115.3% – +101.4% -99.1% +5,328.0% +134.8% +712.1% -98.8% -25.8% -4.1% -68.1%
– -137.7% – +46.2% -203.5% – -10.6% +719.0% -226.5% – -152.5% –
– – – – – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?